Aerie Pharmaceuticals Inc. (AERI) Has Leaped To A New High On Study Results

Aerie Pharmaceuticals Inc. (AERI) announced after the close Wednesday that its Phase 3 study of Roclatan achieved its primary efficacy endpoint.

from RTT - Hot Stocks http://ift.tt/2qZrusL
via IFTTT